QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 biodesix-q3-eps-116-beats-145-estimate-sales-21768m-beat-20974m-estimate

Biodesix (NASDAQ:BDSX) reported quarterly losses of $(1.16) per share which beat the analyst consensus estimate of $(1.45) by 2...

 biodesix-raises-fy2025-sales-guidance-from-80000m-85000m-to-84000m-86000m-vs-83236m-est

Biodesix (NASDAQ:BDSX) raises FY2025 sales outlook from $80.000 million-$85.000 million to $84.000 million-$86.000 million vs $...

 canaccord-genuity-maintains-buy-on-biodesix-lowers-price-target-to-20

Canaccord Genuity analyst Kyle Mikson maintains Biodesix (NASDAQ:BDSX) with a Buy and lowers the price target from $30 to $20.

 stock-market-today-dow-futures-slip-nasdaq-rises-as-trump-files-tariff-appealamerican-eagle-salesforce-lululemon-in-focus-updated

U.S. stock futures were swinging on Thursday following Wednesday's mixed moves. Futures of major benchmark indices were mixed.

 biodesix-stock-surges-over-51-overnight-after-jack-schulers-15m-share-purchase-revealed

Biodesix shares surged over 51% in after-hours trading after major shareholder Jack W. Schuler disclosed a $1.5 million insider...

 biodesix-sees-fy2025-sales-80000m-85000m-vs-82013m-est

Biodesix (NASDAQ:BDSX) sees FY2025 sales of $80.000 million-$85.000 million vs $82.013 million analyst estimate.

 biodesix-q2-eps-008-misses-007-estimate-sales-20018m-beat-18463m-estimate

Biodesix (NASDAQ:BDSX) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.07) by...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION